A Study of Lurbinectedin in Combination With Durvalumab for the Treatment of Participants With ES-SCLC
Abroad (travel likely)RecruitingPHASE2
Conditions
Extensive-stage Small-cell Lung Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Valkyrie Clinical Trials, Inc., Los Angeles, California, United States
Cancer Specialists of North Florida, Jacksonville, Florida, United States
Emory University, Atlanta, Georgia, United States
Carolina Blood and Cancer Care, Rock Hill, South Carolina, United States